Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
312.00 USD | -1.04% | -3.85% | -31.85% |
17/09 | Express Scripts sues FTC over drug pricing report, court documents show | RE |
05/09 | RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 270.7Cr | 336.7Cr | 293.3Cr | 280.6Cr | 248.9Cr | |||||
Depreciation, Depletion & Amortization | 16Cr | 18Cr | 20Cr | 22Cr | 26Cr | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 7Cr | 8.8Cr | 7.3Cr | 9.6Cr | 6.7Cr | |||||
Total Depreciation, Depletion & Amortization | 23Cr | 26Cr | 27Cr | 32Cr | 33Cr | |||||
Amortization of Deferred Charges, Total | 34Cr | 35Cr | 44Cr | 52Cr | 59Cr | |||||
(Gain) Loss On Sale of Asset - (CF) | - | - | - | -24Cr | - | |||||
(Gain) Loss on Sale of Investments - (CF) | -6.2Cr | -84Cr | 13Cr | 20Cr | 5.4Cr | |||||
Total Asset Writedown | - | - | - | 25Cr | 21Cr | |||||
(Income) Loss On Equity Investments - (CF) | -1.4Cr | -7.4Cr | -119.4Cr | 40L | 6.3Cr | |||||
Stock-Based Compensation (CF) | 16Cr | 18Cr | 18Cr | 22Cr | 23Cr | |||||
Provision and Write-off of Bad Debts | - | - | - | - | - | |||||
Change in Accounts Receivable | -3.2Cr | -8.5Cr | -28Cr | -5.4Cr | -34Cr | |||||
Change in Unearned Revenues | -3.6Cr | 7.1Cr | -6.5Cr | 3.2Cr | -2Cr | |||||
Change in insurance Reserves / Liabilities | 114.2Cr | 213.9Cr | 10Cr | 98Cr | 92Cr | |||||
Change in Other Net Operating Assets (Collected) | 59Cr | 1.8Cr | -32Cr | -42Cr | -48Cr | |||||
Other Operating Activities | 25Cr | 24Cr | 5.6Cr | -3.4Cr | -5.9Cr | |||||
Cash from Operations | 528.4Cr | 563.9Cr | 226.2Cr | 458.7Cr | 398.1Cr | |||||
Capital Expenditure | -74Cr | -96Cr | -131.6Cr | -112Cr | -100.4Cr | |||||
Sale of Property, Plant, and Equipment | - | - | - | - | 21Cr | |||||
Cash Acquisitions | - | -71Cr | -418.7Cr | -34Cr | -23Cr | |||||
Divestitures | - | - | - | 270.1Cr | - | |||||
Investment in Marketable and Equity Securities, Total | -54Cr | -139.2Cr | -105.3Cr | -225Cr | -246.5Cr | |||||
Cash from Investing | -127.8Cr | -306.5Cr | -655.6Cr | -100.6Cr | -349.2Cr | |||||
Short Term Debt Issued, Total | 5.4Cr | 39Cr | 36Cr | - | 37Cr | |||||
Long-Term Debt Issued, Total | 99Cr | 208.8Cr | 548.4Cr | 198.2Cr | 254.4Cr | |||||
Total Debt Issued | 104.1Cr | 247.8Cr | 584.2Cr | 198.2Cr | 291Cr | |||||
Short Term Debt Repaid, Total | -101Cr | - | - | -40Cr | - | |||||
Long-Term Debt Repaid, Total | -40Cr | -140Cr | -207.8Cr | -300Cr | -233.2Cr | |||||
Total Debt Repaid | -141Cr | -140Cr | -207.8Cr | -340.4Cr | -233.2Cr | |||||
Issuance of Common Stock | 5.8Cr | 4.9Cr | 2.1Cr | - | - | |||||
Repurchase of Common Stock | -107Cr | -182Cr | -7.9Cr | -209.6Cr | -157.3Cr | |||||
Common Dividends Paid | -29Cr | -32Cr | -35Cr | -39Cr | -53Cr | |||||
Common & Preferred Stock Dividends Paid | -29Cr | -32Cr | -35Cr | -39Cr | -53Cr | |||||
Annuity Receipts | - | - | - | - | - | |||||
Annuity Payments | -62Cr | -94Cr | -31Cr | 199.3Cr | 83Cr | |||||
Other Financing Activities, Total | - | - | -3.1Cr | 30L | -16Cr | |||||
Cash from Financing | -229.5Cr | -195.5Cr | 301.5Cr | -191.4Cr | -86Cr | |||||
Net Change in Cash | 171.1Cr | 62Cr | -127.9Cr | 166.7Cr | -37Cr | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | 21Cr | 26Cr | 28Cr | 35Cr | 39Cr | |||||
Cash Income Tax Paid (Refund) | 52Cr | 113.2Cr | 23Cr | 76Cr | 100Cr | |||||
Net Debt Issued / Repaid | -37Cr | 107.8Cr | 376.4Cr | -142.2Cr | 58Cr | |||||
Levered Free Cash Flow | 232.31Cr | 209.44Cr | 3.74Cr | 450.7Cr | 76Cr | |||||
Unlevered Free Cash Flow | 247.44Cr | 227.12Cr | 24Cr | 475.76Cr | 106.78Cr | |||||
Change In Net Working Capital | -45Cr | 68Cr | 200.9Cr | -214.6Cr | 187.9Cr |